Showing results (301-310 of 1,091) with videos related to
Sort By:
Pageof 110
The American Journal of Medicine|August 1, 1980
Acquired dysfunction due to the circulation of "exhausted" plateletsF I Pareti, A Capitanio, L Mannucci, et al.British Journal of Haematology|March 1, 1982
Treatment of congenital antithrombin III deficiency with concentratesP M Mannucci, C Boyer, M Wolf, et al.Journal Des Maladies Vasculaires|January 1, 1992
[Results of ambulatory and hemodynamic treatment of venous insufficiency (CHIVA cure)]J M Fichelle, P Carbone, C FranceschiThe Biochemical Journal|November 1, 1979
Specific interaction of human Tamm-Horsfall gylcoprotein with leucoagglutinin, a lectin from Phaseolus vulgaris (red kidney bean)F Serafini-Cessi, C Franceschi, S SpertiBritish Journal of Haematology|May 3, 2000
The G1691 --> A mutation of factor V, but not the G20210 --> A mutation of factor II or the C677 --> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulantsM Galli, G Finazzi, F Duca, et al.American Journal of Hematology|March 1, 1992
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentratesA Azzi, S Ciappi, K Zakvrzewska, et al.British Journal of Haematology|April 8, 1998
Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIIIF Peyvandi, E G Tuddenham, A M Akhtari, et al.British Journal of Haematology|November 1, 1982
Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosisS Coccheri, P M Mannucci, G Palareti, et al.Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand diseaseL Baronciani, A B Federici, G Cozzi, et al.American Journal of Hematology|May 1, 1987
Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factorP M Mannucci, M Moia, P Rebulla, et al.Pageof 110